Processa Pharmaceuticals Inc PCSA Q4 2025 Earnings EPS Misses Estimates as Biotech Focuses on Clinical Pipeline MRAM Q1 2026 Earnings EPS Beats Estimates by 19 but Stock Declines on Missing Revenue Details CVU Q1 2021 Earnings Strong EPS Beat Drives Positive Stock Reaction ABVX Q4 2025 Earnings Significant EPS Miss as DevelopmentStage Biotech Reports WiderThanExpected Loss BILL Q1 2026 Earnings EPS Surpasses Estimates by Nearly 20 on Operational Discipline Gladstone Commercial GOOD Holds Steady Near Support as REIT Sector Eyes Stability Bed Bath Beyond BBBY Slips 227 Amid Ongoing Struggles Key Levels to Monitor Wolverine World Wide WWW Edges Higher as Stock Tests Key Resistance Zone Hawaiian Electric HE Slips 073 as Utility Sector Pressure Persists NE Q1 2026 Earnings EPS Beats Estimates by 301 Stock Declines